111327 ⎘
ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV Methods of inactivation or attenuation
Sub-classes:ATTENUATED VIRUSES USEFUL FOR VACCINES
#2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
#3Methods and compositions for live attenuated viruses
#4Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#5Attenuated viruses useful for vaccines
#6iDNA vaccines and methods for using the same
#7Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
#8Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#9Methods and compositions for live attenuated viruses
#10Methods of making modified viral genomes
#11Dengue virus vaccine composition
#12Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
#13IDNA vaccines and methods for using the same
#14Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
#15Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#16Subgenomic replicons of the flavivirus dengue
#17Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
#18IDNA vaccines and methods for using the same
#19Flavivirus host range mutations and uses thereof
#20Inactivated chimeric vaccines and related methods of use
#21Attenuated live vaccines
#22Recombinant bicistronic flaviviruses and methods of use thereof
#23Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
#24CHIMERIC SLE/DENGUE TYPE 4 ANTIGENIC VIRUSES
#25Chimeric flavivirus vaccines
#26Subgenomic replicons of the flavivirus dengue
#27Attenuated viruses useful for vaccines
#28West nile virus vaccine
#29Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#30Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
#31Inactivated Chimeric Vaccines and Related Methods of Use
#32Attenuated virus strains and uses thereof
#33Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
#34Methods and compositions for live attenuated viruses
#35Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone
#36Live Attenuated Dengue 3 Virus Strains
#37West nile virus vaccine
#38Chimeric West Nile viruses and uses thereof
#39Attenuated dengue virus comprising mutations in the NS3 gene
#40West nile virus vaccine
#41Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
#42Inactivated chimeric flavivirus
#43Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents
#44Flavivirus variants having phenotypic variation and immunogenic compositions thereof
#45Infectious DNA as a vaccine against west nile and other flaviviruses
#46Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
#47West nile virus vaccine
#48Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses